We are pleased to invite shareholders to attend Open House meetings in Melbourne and Sydney to discuss the company’s strategy and recent progress.
The Open House meetings will be attended by members of the company’s senior management team, including CEO, Dr James Garner. Dr Garner will give a short presentation on the company’s activities and will then answer questions from shareholders.
The following sessions are available to those shareholders able to attend:
Melbourne
Monday 9 September 2024, 5pm – 6pm
Offices of MinterEllisonL20, Collins Arch,
447 Collins Street,
Melbourne, VIC 3000
Sydney
Monday 16 September 2024, 5pm – 6pm
Offices of MinterEllison 40 Governor Macquarie Tower,
1 Farrer Place,
Sydney, NSW 2000
Shareholders wishing to attend are asked to register in advance via the links provided, or by emailing Percheron Therapeutics Investor Relations on info@PercheronTx.com. If responding via email, shareholders should provide their name, email address, contact number, and an indication of which session they wish to attend (Melbourne or Sydney).
Please note that registration is essential so that attendee lists may be provided to building security in advance of each event, and we will not be able to accommodate walk-ins.
The Percheron team looks forward to meeting shareholders who are able to attend. We recognise that the timing and location of such meetings can never be convenient to all who may wish to attend, but we look forward to meeting shareholders in other locations at future events
